R.N. Jadeja et al. / Polyhedron 31 (2012) 767–778
769
added with a sterile micropipette. The plates were then incubated
2.6. Synthesis of Cu(TP)2
at 35 2 °C for 24 h for bacteria. Inhibition was recorded by mea-
suring the diameter of the inhibitory zone after the period of incu-
bation. All the experiments were repeated thrice and the average
values are presented.
Copper complexes were prepared with the following procedure:
an ethanolic solution (60 cm3, 0.2 mM) of the ligand was added to a
methanolic solution (10 cm3, 0.1 mM) of Cu(II) acetate monohy-
drate. A green precipitate was formed immediately. The reaction
mixture was set aside overnight and the solid product was filtered
off, washed with methanol and recrystallized from acetonitrile.
The reaction was carried out under a N2 stream [30]. Solvents were
dried by standard techniques.
2.4. Synthesis of 4-toluoyl pyrazolones [TP]
5-Methyl-4-(4-methyl-benzoyl)-2-phenyl-2,4-dihydro-pyrazol-3-
one (PMP) was prepared by the interaction of 5-methyl-2-phenyl-
2,4-dihydro-pyrazol-3-one in dioxane with calcium hydroxide and
benzoyl chloride by the procedure reported by Jensen [23]. Following
the same procedure, 2-(3-chloro-phenyl)-5-methyl-4-(4-methyl-ben-
zoyl))-2,4-dihydro-pyrazol-3-one [MCPMP] and 5-methyl-4-(4-
methyl-benzoyl)-2-p-tolyl-2,4-dihydro-pyrazol-3-one [PTPMP] were
prepared using 2-(3-chloro-phenyl)-5-methyl-2,4-dihydro-pyrazol-
3-one and 5-methyl-2-p-tolyl-2,4-dihydro-pyrazol-3-one, respec-
tively. 2-(3-Chloro-phenyl)-5-methyl-4-(4-methyl-benzoyl))-2,4-dih
ydro-pyrazol-3-one [MCPMP] and 5-methyl-4-(4-methyl-benzoyl)-
2-p-tolyl-2,4-dihydro-pyrazol-3-one [PTPMP] were prepared analo-
gously from 2-(3-chloro-phenyl)-5-methyl-2,4-dihydro-pyrazol-3-
one and 5-methyl-2-p-tolyl-2,4-dihydro-pyrazol-3-one, respectively.
PMP is cream crystals. Yield 80.85% m.p. 120 °C Anal. Calc. for
Complex 1 is green crystals. Yield 44.62%, m.p. >240 °C. Anal. Calc.
for C36H30CuN4O4 (M.W. 646.18): C, 66.91; H, 4.68; N, 8.67; Cu, 9.83.
Found: C, 66.81; H, 4.62; N, 8.59; Cu, 8.99%. IR (KBr, cmÀ1): 1571 (s)
(C@N, cyclic), 1215 (s) (C@N, azomethane), 1484 (m) (C–O), 479 (m)
(Cu–O); UV–Vis (DMF): kmax/nm 722 (
2B1g ? 2A1g
Square planar; Molar conductance (DMF,
À1 cm2 molÀ1): 7.00.
Complex 2 is green crystals. Yield 45.73%, m.p. >250 °C. Anal. Calc.
e
/dm3 molÀ1 cmÀ1 7368,
,
X
for C36H28CuN4O4Cl2 (M.W. 715.06): C, 60.47; H, 3.95; N, 7.83; Cu,
8.89. Found: C, 60.50; H, 3.93; N, 7.76; Cu, 8.78%. IR (KBr, cmÀ1):
1570 (s) (C@N, cyclic), 1220 (s) (C@N, azomethane), 1472 (m) (C–
O), 482 (m) (Cu–O); UV–Vis (DMF): kmax/nm 719 (
7004, 2B1g ? 2A1g
Square planar; Molar conductance (DMF,
À1 cm2 molÀ1): 11.00.
Complex 3 is also green crystals. Yield 41.04% m.p. >240 °C. Anal.
e
/dm3 molÀ1 cmÀ1
,
C18H16N2O2 (M.W. 292.33): C, 73.95; H, 5.52; N, 9.52. Found: C,
X
73.68; H, 5.21; N, 9.51%. 1H NMR (CDCl3): d 2.16 (s, 3H, PZ C–
CH3), 2.47 (s, 3H, N-TL C–CH3), 7.28–7.46 (m, 5H, Ph), 7.49–7.59
(m, 4H, TL), 7.88–7.90 (s, 2H, PZ ring). IR (KBr, cmÀ1): 1598 (s)
(C@N, cyclic), 1641 (m) (C@O, pyrazolone ring), 1225 (s) (C@N,
azomethane); 13C NMR (CDCl3) d: 16.04 [C–CH3, PZ], 21.70 [C–
CH3, TL], 103.56 [C@O], 120.73–129.14 [substituted benzene
rings]; MS: m/z = 292.07 [C18H16N2O]+, 214.05 [C12H11N2O2]+,
200.03 [C11H9N2O2]+, 119.04 [C8H7O]+, 91.06 [C7H7]+.
Calc. for C38H34CuN4O4 (M.W. 674.23): C, 67.69; H, 5.08; N, 8.31; Cu,
9.42. Found: C, 67.61; H, 5.05; N, 8.25; Cu, 8.78%. IR (KBr, cmÀ1):
1571 (s) (C@N, cyclic), 1217 (s) (C@N, azomethane), 1480 (m) (C–
O), 480 (m) (Cu–O); UV–Vis (DMF): kmax/nm 722 (
7580, 2B1g ? 2A1g
Square planar; Molar conductance (DMF,
À1 cm2 molÀ1): 10.00.
e
/dm3 molÀ1 cmÀ1
,
X
2.7. Crystal structure determination and refinement
MCPMP is brownish yellow crystals. Yield 81.20% m.p. 100 °C.
Anal. Calc. for C18H15N2O2Cl (M.W. 326.78): C, 66.16; H, 4.63; N,
8.57. Found: C, 66.20; H, 4.52; N, 8.51%. 1H NMR (CDCl3): d 2.15 (s,
3H, PZ C–CH3), 2.47 (s, 3H, N-TL C–CH3), 7.25–7.41 (m, 4H, Ph),
7.56–7.85 (m, 4H, TL), 7.87–7.98 (s, 2H, PZ ring). IR (KBr, cmÀ1):
1580 (s) (C@N, cyclic), 1635 (m) (C@O, pyrazolone ring), 1230 (s)
(C@N, azomethane); 13C NMR (CDCl3): d 16.13 [C–CH3, PZ], 21.72
[C–CH3, TL], 103.59 [C@O], 118.14–148.23 [substituted benzene
ring], 162.90 [C–Cl]; MS: m/z = 326.03 [C18H15N2O2Cl]+, 290.53
[C18H15N2O2]+, 214.07 [C11H8N2O2Cl]+, 200.05 [C11H9N2O2]+,
119.05 [C8H7O]+, 91.07 [C7H7]+
Crystals having good morphology were chosen for three-dimen-
sional intensity data collection. X-ray intensity data of the com-
plexes Ca(PMP)2(EtOH)2 and Cu(PMP)2 were collected at room
temperature on Bruker CCD area-detector diffractometer equipped
with graphite monochromated MoK
a radiation (a = 0.71073 Å).
The crystals used for data collection were of suitable dimensions.
The unit cell parameters were determined by least-square refine-
ments of all reflections in both cases. All the structures were solved
by direct method and refined by full-matrix least squares on F2.
Data were corrected for Lorentz, polarization and multi-scan
absorption correction [31]. The structures were solved by direct
methods using SHELXS97 [32]. All non-hydrogen atoms of the mole-
cule were located in the best E-map. Full-matrix least-squares
refinement was carried out using SHELXL97 [32]. Hydrogen atoms
were placed at geometrically fixed positions and allowed to ride
on the corresponding non-H atoms with C–H = 0.93–0.96 Å, and Ui-
so = 1.5 Ueq of the attached C atom for methyl H atoms and 1.2 Ueq
for other H atoms. Atomic scattering factors were taken from Inter-
national Tables for X-ray Crystallography (1992, Vol. C, Tables
4.2.6.8 and 6.1.1.4). An ORTEP [33] view of the both the complexes
with atomic labeling are shown in Figs. 1 and 2. The geometry of
the molecule has been calculated using the software PLATON
[34] and PARST [35]. The crystallographic data are summarized
in Table 1.
PTPMP is yellow crystals. Yield 80.25% m.p. 150 °C Anal. Calc. for
C
19H18N2O2 (M.W. 306.36): C, 74.49; H, 5.92; N, 9.14. Found: C,
74.39; H, 5.87; N, 9.03%. 1H NMR (CDCl3): d 2.19 (s, 3H, PZ C–
CH3), 2.46 (s, 3H, N-TL C–CH3), 7.27–7.33 (m, 4H, Ph), 7.56–7.76
(m, 4H, TL); IR (KBr, cmÀ1): 1543 (s) (C@N, cyclic), 1630 (m)
(C@O, pyrazolone ring), 1222 (s) (C@N, azomethane); 13C NMR
(CDCl3): d 16.00 [C–CH3, PZ], 21.69 [C–CH3, TL], 103.56 [C@O],
120.73–129.14 [substituted benzene rings]; MS: m/z = 306.08
[C19H18N2O2]+, 214.95 [C12H11N2O2]+, 185.12 [C11H11N2O]+,
123.82 [C5H4N2O2]+, 119.05 [C8H7O]+, 91.04 [C7H7]+.
2.5. Synthesis of Ca(PMP)2(EtOH)2
Ca(II) complex was prepared by the following method. The metal
salt was dissolved in ethanoland the solutionwas added to a hot eth-
anolic solution of the ligand. After the complete addition little
amount of sodium acetate was added and the mixture was refluxed
for 4 h. A crystalline solid was obtained, which was isolated by filtra-
tion and recrystallized from acetonitrile. Cream crystals; Yield
70.94% m.p. 200–205 °C. Anal. Calc. for C40H42N4O6Ca (M.W.
714.86): C, 67.20; H, 5.92; N, 7.83; Ca, 5.60. Found: C, 67.40; H,
5.86; N, 7.76; Ca, 5.55%. IR (KBr, cmÀ1): 1543 (s) (C@N, cyclic),
1210 (s) (C@N, azomethane), 1492 (m) (C–O), 429 (m) (Ca–O).
3. Results and discussion
3.1. Physicochemical properties of the synthesized ligands and their
complexes
The ligands and their complexes were synthesized in a very fac-
ile and essentially identical way. The Ligand acts as a bidentate O,